Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bangun Kosambi Sukses Tbk. (CBDK) vs Tempo Scan Pacific Tbk. (TSPC)

Bangun Kosambi Sukses Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bangun Kosambi Sukses Tbk. dan Tempo Scan Pacific Tbk.: Bangun Kosambi Sukses Tbk. diperdagangkan di Rp3.500 (kapitalisasi pasar 19,5 T, volume 24 jam 1,85 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Bangun Kosambi Sukses Tbk. lebih besar dari sisi kapitalisasi pasar, dan Bangun Kosambi Sukses Tbk. lebih aktif diperdagangkan (1,85 jt vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.

CBDKTSPC
Kapitalisasi Pasar
19,5 T11,18 T
Volume
1,85 jt613 rb
Lot
18,52 rb6,13 rb
Perputaran
6,5 M1,54 M
Harga Rata-rata
3.512,142.511,52
Nilai Transaksi
6,5 M1,54 M
Harga Ekuilibrium Indikatif
3.5002.520
Volume Ekuilibrium Indikatif
52217

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

CBDK
Lihat detail
TSPC
Lihat detail

Tentang Bangun Kosambi Sukses Tbk.

PT Bangun Kosambi Sukses Tbk (the Company) was established based on Notarial Deed No. 01 of Djedjem Widjaja, S.H., M.H., dated 3 April 2000. The Company commenced its commercial operations in 2020. The Company is controlled by its immediate parent company, PT Pantai Indah Kapuk Dua Tbk, domiciled in Jakarta and its ultimate parent companies are PT Agung Sedayu and PT Tunas Mekar Jaya, domiciled in Jakarta.

Selengkapnya di halaman CBDK

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC